eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
At close: Jun 26, 2026
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $2.82 thousand as of June 26, 2026. Its market cap has decreased by -98.77% in one year.
Market Cap
2.82K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 2.82K, a decrease of -100.00%. That is a compound annual growth rate of -87.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.82K | 200.00% |
| Dec 31, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | -100.00% |
| Dec 29, 2023 | 30.20M | 68.61% |
| Dec 30, 2022 | 17.91M | -94.64% |
| Dec 31, 2021 | 334.28M | 52.66% |
| Mar 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevena | 1.44K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| TetraLogic Pharmaceuticals | 973.00 |
| Panbela Therapeutics | 971.00 |
| RegeneRx Biopharmaceuticals | 905.00 |
| Pathfinder Cell Therapy | 667.00 |